Orlucent
CA - Los GatosBiotechnology
Focus: Orlucent develops a skin fluorescent imaging device (Melanoma Detection System) for non-invasive evaluation of skin lesions and nevus to aid in melanoma detection. The company is a pre-revenue medical device biotech operating in dermatologic diagnostics.
Profile data last refreshed 17h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Orlucent
AI assessmentNot HiringNo open roles listed right now. Follow Orlucent to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Orlucent's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Skin Fluorescent Imaging
NevusClinical Trials (1)
NCT04368247Skin Fluorescent Imaging (SFI) System in Patients With Nevi
N/AHelp build intelligence for Orlucent
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.